The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Argenica Therapeutics (AGN) receives a $1.2 million grant from the Australian Federal Government for traumatic brain injury (TBI) preclinical research
  • The cash was awarded under the Cooperative Research Centre Project program, which matches funding for projects
  • The project will see Argenica test the efficacy of its ARG-007 drug in preclinical animal models with mild repeated and moderate TBI
  • Argenica, along with its collaboration partners, will be required to make up the remaining $1.5 million of the $2.7 million project
  • AGN shares were up 4.49 per cent, trading at 46.5 cents at 11:40 am AEDT

Argenica Therapeutics (AGN) has been awarded a $1.2 million grant from the Australian Federal Government for traumatic brain injury (TBI) preclinical research.

The funding was awarded under the Cooperative Research Centre Project program (CRC-P) and will go towards Argenica testing the efficacy of its ARG-007 drug in preclinical animal models of mild repeated and moderate TBI.

The project will be undertaken in collaboration with Curtin University in Perth, the University of Adelaide, peptide manufacturer AusPep, and Connectivity Traumatic Brain Injury Australia.

The project will build on previous preclinical studies showing ARG-007 reduces damage to neuron axonal injury and promotes brain cell proliferation following severe TBI.

The total cost of the project will be around $2.7 million, with Argenica and its project collaborators providing the remaining $1.5 million in addition to the grant from the CRC-P program which provides matched funding.

The $1.5 million is planned to be made up from salary, cash and in-kind contributions.

All intellectual property and commercialisation rights will remain solely with Argenica.

AGN shares were up 4.49 per cent, trading at 46.5 cents at 11:40 am AEDT.

AGN by the numbers
More From The Market Online
The Market Online Video

ASX Daily Close: ASX matches futures prediction on a green Friday | 21 June 2024

The ASX200 reversed its trend to end the week in the green, up 0.35%. Nearly all…
The Market Online Video

ASX Market Update: Stocks swing from green with energy to remorseful red | 21 June, 2024

The ASX200 came out the gate in the green on Friday, but slipped well below the red line within the first hour of

Week 25 Wrap: No RBA cut yet; India stocks shake off Modi jitters; China concerns remain

The RBA keeps rates on pause; Guzman Gomez falls nearly -5% on Friday; Droneshield's new ATH;…

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

The one defining feature of our post-COVID 'new normal' is a USA swing towards domestic supply…